Screener
Cumberland Pharmaceuticals CPIX Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Cumberland Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Cumberland Pharmaceuticals’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 5:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001087294-26-000062
FAQ
- What is Cumberland Pharmaceuticals's net income?
- Cumberland Pharmaceuticals (CPIX) reported net income of -$4.28M in Q2 2026.
- How has Cumberland Pharmaceuticals's net income changed year-over-year?
- Cumberland Pharmaceuticals's net income decreased by 477.3% year-over-year, from -$740.74K to -$4.28M.
- What is the long-term trend for Cumberland Pharmaceuticals's net income?
- Over 4 years (2021 to 2025), Cumberland Pharmaceuticals's net income has grown at a -5.2% compound annual growth rate (CAGR), from -$3.51M to -$2.84M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Cumberland Pharmaceuticals's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude